Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
Kanako Kikuchi, president of GlaxoSmithKline K.K., the Japan arm of GlaxoSmithKline PLC, will step down at the end of this year, only nine months after she took office in April as the local unit’s first Japanese president. According to a…
To read the full story
Related Article
- Former GSK Japan Chief Kanako Kikuchi Named UCB Japan President
April 19, 2018
- GSK Canada Head Tapped for Japan President
January 10, 2018
- GSK Poised to Re-Enter Japan Oncology Space with Novel Myeloma Drug
December 6, 2017
- Kanako Kikuchi to Become Japan Chief of GSK
March 7, 2017
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





